$5.48 0.18 (+3.40%)
11/6/2009 4:00 PM

Inspire Pharmaceuticals, Inc. (ISPH)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products in disease areas with commercial potential or unmet medical needs.

Current Price $5.48 Mkt Cap $310.8M
Open $0.00 P/E Ratio 0.00
Prev. Close $5.30 Div. (Yield) N/A (N/A)
Daily Range $5.10 - $5.59 Volume 1,084,841
52-Wk Range $2.59 - $6.54 Avg. Daily Vol. 600,000

ISPH News and Commentary

Caps

How do you think ISPH will perform vs the S&P 500?

Add Stock to Watchlist

All Members

78 Outperform
11 Underperform
 

All-Star Members

23 Outperform
0 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top ISPH Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Gtrinvestor (99.97)
Submitted January 04, 2008

Re-load on this stock due to the no-news recent drop in the stock's price. In addition, some recent articles on this one have given me further interest in this stock beyond just ISV (which I assert as my mine reason for investing in this stock… More

2 Comments | Reply | Report this Post

jc33sil22 (< 20)
Submitted August 09, 2007

the price just hit the few month high. the resistance at this level is very high. the relative strength is deteriorating.

0 Comments | Reply | Report this Post
ISPH VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about ISPH.

Recs

0
Member Avatar Fiskhus (85.66) Submitted: 2/24/2009 11:22:53 PM : Outperform Start Price: $3.74 ISPH Score: +5.20

LMS= AA* 1%50 = AorN

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar cashsage (60.05) Submitted: 1/7/2009 4:18:40 PM : Underperform Start Price: $3.29 ISPH Score: -45.64

ISPH has a too high valuation compared to its sales potential. It is also loss making and does not distribute any dividend. ISPH changed rating from 3 stars to 2 stars yesterday.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar manvsmonkey (68.81) Submitted: 6/20/2008 2:53:26 PM : Outperform Start Price: $4.33 ISPH Score: +42.39

ISV - don't know why that stock is dropping. Their product is solid and has potential for many permutations.

ISPH might be a better bet monetarily since they have the license to market the Azasite brand.

quoted from ISV website-

"Inspire Pharmaceuticals (NASDAQ:ISPH) has the responsibility to commercialize AzaSite in the U.S. and Canada in accordance with a completed license agreement. Ongoing activities are focused on licensing AzaSite in markets outside of the U.S. and Canada. "

Report this Post 0 Comments | Reply | Permalink
View All 12 Pitches »

Leaderboard

Find the members with the highest scoring picks in ISPH.

Score Leader

aracer

aracer (99.63) Score: +107.00

The American people will never knowingly adopt socialism, but under the name of liberalism they will adopt every fragment of the socialist program until one day America will be a socialist nation without ever knowing how it happened.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
ILOVELOVE < 20 9/9/2008 Outperform NS $3.75 +46.13% -11.57% +57.70
JealousAgain 87.46 7/25/2008 Outperform NS $3.87 +41.60% -12.15% +53.75
HotlyCool 78.67 7/25/2008 Outperform NS $3.87 +41.60% -12.15% +53.75
IShotJR 51.63 7/25/2008 Outperform NS $3.87 +41.60% -12.15% +53.75
BearNekkid 80.63 7/25/2008 Outperform NS $3.87 +41.60% -12.15% +53.75
SlowQuarter 49.95 7/25/2008 Outperform NS $3.88 +41.42% -11.82% +53.23
scottl266 61.24 4/15/2008 Outperform 3M $4.03 +35.98% -16.77% +52.75
TeeBoonePickens 92.05 7/23/2008 Outperform NS $3.98 +37.69% -13.64% +51.33
myfirstfund 31.42 7/28/2008 Outperform 3Y $4.00 +37.00% -11.92% +48.92
2st6 90.93 1/8/2009 Outperform NS $3.29 +66.57% +21.32% +45.24
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackWedbush < 20 5/8/2009 Outperform NS $4.04 +40.59% +18.02% +22.57 9/23/2009 @ $5.68
TrackZacks 69.52 11/3/2008 Outperform 3M $3.95 +38.73% +13.17% +25.56 1 Comment
TrackZacks 69.52 8/13/2007 Outperform 3M $5.87 -49.23% -31.96% -17.27 10/20/2008 @ $2.98 1 Comment
TrackPacificGrow 90.86 5/15/2007 Outperform NS $6.59 -16.84% -25.05% +8.21
TrackDeutscheSec 89.50 2/28/2007 Outperform NS $6.88 -20.35% -19.33% -1.02
TrackCollinsStew 68.32 12/5/2006 Outperform NS $5.08 +7.87% -19.68% +27.55

Featured Broker Partners